GMP | MHRA

Total Records 981 to 990 of 1631

GMP Search Results
Certificate Number	GMPC or Non-compliance	Site Details	Country	Inspection Date Sort ascending
UK MIA(IMP) 41690 Insp IMP 41690/6962705-0005[I]	GMPC	MYLAN PHARMA UK LIMITED, IPC 008, DISCOVERY PARK HOUSE, FLOOR 3, RAMSGATE ROAD, SANDWICH, CT13 9ND, UNITED KINGDOM	UNITED KINGDOM	15/05/2018
UK GMP 48658 Insp GMP 48658/17544075-0001[H]	GMPC	BEIJING YILING BIO-ENGINEERING TECHNOLOGY COMPANY LIMITED, NO. 23 KEJI ROAD, INDUSTRY PARK, MIYUN, BEIJING, CN 101500, CHINA	CHINA	14/05/2018
UK GMP 17543 Insp GMP 17543/9621-0024 [V]	GMPC	INTAS PHARMACEUTICALS LIMITED, PLOT NUMBERS 457,458 & 191/218P, SARKHEJ- BAVLA HIGHWAY, MATODA, SANAND, AHMEDABAD, IN-382210, INDIA	INDIA	14/05/2018
UK GMP 17543 Insp GMP 17543/9621-0024 [H]	GMPC	INTAS PHARMACEUTICALS LIMITED, PLOT NUMBERS 457,458 & 191/218P, SARKHEJ- BAVLA HIGHWAY, MATODA, SANAND, AHMEDABAD, IN-382210, INDIA	INDIA	14/05/2018
UK GMP 29338 Insp GMP 29338/443841-0008[H]	GMPC	FRESENIUS KABI ONCOLOGY LIMITED, VILLAGE KISHANPURA, BADDI, TEHSIL NALAGARH, DISTRICT SOLAN, IN-174101, INDIA	INDIA	30/04/2018
UK GMP 14694 Insp GMP 14694/1071930-0009[H]	GMPC	CIPLA LIMITED (UNIT IV), UNIT IV, PLOT L-139, S-103 & M-62, VERNA INDUSTRIAL ESTATE, VERNA, IN-403 722, INDIA	INDIA	28/04/2018
UK GMP 49634 Insp GMP 49634/18377255-0001 [V]	GMPC	ABSORPTION SYSTEMS, 436 CREAMERY WAY, SUITE 600, EXTON, 19341, UNITED STATES	UNITED STATES	19/04/2018
UK GMP 49634 Insp GMP 49634/18377255-0001 [H]	GMPC	ABSORPTION SYSTEMS, 436 CREAMERY WAY, SUITE 600, EXTON, 19341, UNITED STATES	UNITED STATES	19/04/2018
UK GMP 33881 Insp GMP 17350/5879877-0006[H]	GMPC	GLENMARK PHARMACEUTICALS LIMITED, PLOT NO. 2, PHASE II, PHARMA ZONE, SEZ, PITHAMPUR, DISTRICT DHAR, IN 454775, INDIA	INDIA	19/04/2018
UK GMP 49750 Insp GMP 49750/18408930-0001[H]	GMPC	TERUMO YAMAGUCHI D&D CORPORATION, 3-22, AZAMURAYAMA, SAYAMA, YAMAGUCHI, JP-754-0894, JAPAN	JAPAN	18/04/2018

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX